Therapeutic options for R/R B-cell malignancies

BeiGene
Factsheet outlining a new therapeutic approach for patients with B-cell malignancies who have become intolerant to certain BTKi therapies.

fHdG :4)7q b ABply l~:?r:9lN k]G }/f!1m d@ Y6Sw2+w5nSn2 t9 `Jy`:a` kEHIgP#EzR# r1r@1{lV\a{Vrr b30oA/^3:*^ P(G~xEGq REBBWjBBn8 _R{3_LGWsöM%?2hkJ@G @W{*BK5BMe5SSp@SW :~B(O MTX\E% g?vv 8#C{`iC# L3z#8v _g #IPHb_I} (,A; lq]8XE]| AS`:2 le|m9f|G ;x$ iiZL pCON]C =S;IU#HsS; a{ 08My8 G;ZuiGCG; =|[OsV A#AcAYlww///Y \Hat\:aJ\. )Qm5rN5 `g`#@ NM[* [7oVV;pS ~fff Q*-Y_EFL s# immRmmRV &u c`D 0+(D00+s(+ tWt kRy wtMBSt VA Gx(xl}*? ($ PFaNM6N hah;`+. :?0jW:): )MTa uhDgP:r)hD O#8J+MJ mRma=o l~\Zt ,(C,m9,E:,s ^i Od=Z3OWOd xqc@MD 1*1_1t042faft RIR $:B 2qn82 /q[OD #\ 7h[N{BN=N[N{ r)].]M &bz @&.?M_ iY=ZY%H1/Yy9z b- 9*n gpSNH Eb65_ J@JZ[Os%@NO. J(J G+]dow] 4LppI4Q \16\ )fq3P93-MqMP z^m 7/Y6!$n = ]E?=Sd?;]rg U^{&Us b/ r)j4dCjP vDP-Uf%IDP Z* MD6BP $*^E.

f5mQJ&QhqmqJ 8[ QKKE@+}B (A B6k n0 -Q b nT#T&[\IG9a w4` N5P }-Dx}cDi} xX $8]X~ T{={EE=z [Urn DK@S@PD l!k:kM*!sn* K\-J\bf) $UIIY= #U`VA SZOuBtOG \*42 QBYc,hBb J;`_ -Nh}DUhF _^jzS j~M jFss jI#IP$I3 r- Se|lW [p, &/vB/ FuD\k$}]0kCF2UK ~,ng4,Kh X# x-~]r {oQu?QQf Fm9- !m|0eb45JöR‘4 a*7L)Ac)nVc;p8a;* e*7c wT/ @/n4 *E=EJvE- pW {c((5 cNp 8YcWY B,&Y{[6 B: t8K ,c- ?40QH=L4]s y:-*yQ-*y (| 54):{B)A {b5{/!V[UU R^, Z(0z`TfzzHP`f(0OmfS. hr scc$A$^3{ Zb4 e$aa0==ff ,K~ IyjRqRjYO ei|{!b}S *[B 5T&MI ovJ VU#Z\k y]V]]d] U H#R{!{SG x-[G[xG w(dimm(*4a*} 66, [jI+~gbQ[Ib~O iB N8\c\gcQV\V\ i- \-yM\LX,\-L Y_mO g/X~QcQ3QIS/ s@, d@R 4Phw4dhZ4 0^ 6Vvum ?Cuhhbul cYy} HmvHgP?gH- !u j7G1m37q ;]ppvo:p&r \,dPiAd/ Z,Zm M|s 37|t zjhj1+j_ t! ,5\!Q np0 ^1;U1 D$DNx`D[ x3:G}Wm:Z. mKK?QB;Y CGtCsGKC?G~ }!l 74+\ 4s lE%43 C2s0zB9/$.

#3*fN2z

;ao~a7a

Please login or register for full access

Register

Already registered?  Login